Select Publications
Journal articles
2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'The modifiable burden of worldwide mortality from cardiovascular diseases', LANCET DIABETES & ENDOCRINOLOGY, 2, pp. 604 - 606, http://dx.doi.org/10.1016/S2213-8587(14)70040-3
,2014, 'Is it time for medi-change?', Medical Journal of Australia, 200, pp. 566 - 567, http://dx.doi.org/10.5694/mja14.00427
,2014, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD007784.pub2
,2014, 'The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy', Journal of the American Society of Nephrology, 25, pp. 1083 - 1093, http://dx.doi.org/10.1681/ASN.2013080830
,2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378
,2014, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD005019.pub4
,2014, 'Authors' reply to Ladapo and Ogedegbe', BMJ (Online), 348, http://dx.doi.org/10.1136/bmj.g148
,2014, 'Cardiovascular disease in patients with chronic kidney disease', Nephrology, 19, pp. 3 - 10, http://dx.doi.org/10.1111/nep.12148
,2014, 'Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials', American Journal of Kidney Diseases, 63, pp. 968 - 978, http://dx.doi.org/10.1053/j.ajkd.2014.01.435
,2014, 'Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy', American Journal of Nephrology, 40, pp. 64 - 74, http://dx.doi.org/10.1159/000364909
,2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391
,2014, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Sao Paulo Medical Journal, 132, pp. 314, http://dx.doi.org/10.1590/1516-3180.20141325T1
,2014, 'Optimal targets for blood pressure control in chronic kidney disease: The debate continues', Current Opinion in Nephrology and Hypertension, 23, pp. 541 - 546, http://dx.doi.org/10.1097/MNH.0000000000000060
,2014, 'The modifiable burden of worldwide mortality from cardiovascular diseases', The Lancet Diabetes and Endocrinology, 2, pp. 604 - 606, http://dx.doi.org/10.1016/S2213-8587(14)70040-3
,2014, 'The relative and combined ability of high-sensitivity cardiac troponin t and n-terminal pro-b-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes', Diabetes Care, 37, pp. 295 - 303, http://dx.doi.org/10.2337/dc13-1165
,2013, 'Erratum: Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials (Nephrology Dialysis Transplantation (2013) 28:11 (2875-2888) DOI: 10.1093/ndt/gft406)', Nephrology Dialysis Transplantation, 28, pp. 3127, http://dx.doi.org/10.1093/ndt/gft501
,2013, 'Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction', Diabetes Care, 36, pp. 3460 - 3468, http://dx.doi.org/10.2337/dc13-0323
,2013, 'Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: Meta-analysis of randomised controlled trials', BMJ (Online), 347, http://dx.doi.org/10.1136/bmj.f5680
,2013, 'ACEIs for cardiovascular risk reduction: Have we taken our eye off the ball?', Australian Family Physician, 42, pp. 634 - 638
,2013, 'Industry-sponsored clinical trials in emerging markets: Time to review the terms of engagement', JAMA, 310, pp. 907 - 908, http://dx.doi.org/10.1001/jama.2013.276913
,2013, 'ACEIs for cardiovascular risk reduction Have we taken our eye off the ball?', AUSTRALIAN FAMILY PHYSICIAN, 42, pp. 634 - 638, http://search.informit.com.au/documentSummary;dn=537302915216331;res=IELHEA
,2013, 'The authors reply', Kidney International, 84, pp. 622, http://dx.doi.org/10.1038/ki.2013.241
,2013, 'Tripterygium preparations for the treatment of CKD: A systematic review and meta-analysis', American Journal of Kidney Diseases, 62, pp. 515 - 530, http://dx.doi.org/10.1053/j.ajkd.2013.02.374
,2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3
,2013, 'Antioxidants for chronic kidney disease', Nephrology, 18, pp. 576 - 578, http://dx.doi.org/10.1111/nep.12103
,2013, 'Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis', CMAJ. Canadian Medical Association Journal, 185, pp. 949 - 957, http://dx.doi.org/10.1503/cmaj.121468
,2013, 'High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus', European Heart Journal, 34, pp. P1546 - P1546, http://dx.doi.org/10.1093/eurheartj/eht308.p1546
,2013, 'Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and meta-analysis', European Heart Journal, 34, http://dx.doi.org/10.1093/eurheartj/eht065
,2013, 'Effekt des DPP-4-Inhibitors Linagliptin auf die Albuminurie bei Patienten mit Typ-2-Diabetes und diabetischer Nephropathie', Diabetologie und Stoffwechsel, 8, http://dx.doi.org/10.1055/s-0033-1341903
,2013, 'Antiplatelet agents for chronic kidney disease.', Cochrane database of systematic reviews (Online), 2
,2013, 'Epidemiology: Global Burden of Disease Study 2010: Implications for nephrology', Nature Reviews Nephrology, 9, pp. 195 - 197, http://dx.doi.org/10.1038/nrneph.2013.38
,2013, 'Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: A systematic review and meta-analysis', Anesthesiology, 118, pp. 809 - 824, http://dx.doi.org/10.1097/ALN.0b013e318287b72c
,2013, 'MTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): The question remains open', Nephrology Dialysis Transplantation, 28, pp. 242 - 244, http://dx.doi.org/10.1093/ndt/gfs519
,2013, 'Outcomes of extended-hours hemodialysis performed predominantly at home', American Journal of Kidney Diseases, 61, pp. 247 - 253, http://dx.doi.org/10.1053/j.ajkd.2012.08.032
,2013, 'Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials', Nephrology Dialysis Transplantation, 28, pp. 2875 - 2888, http://dx.doi.org/10.1093/ndt/gft406
,2013, 'Antiplatelet agents for chronic kidney disease', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD008834.pub3
,2013, 'Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis', American Journal of Kidney Diseases, 61, pp. 112 - 122, http://dx.doi.org/10.1053/j.ajkd.2012.08.031
,2013, 'Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus', Kidney International, 83, pp. 278 - 284, http://dx.doi.org/10.1038/ki.2012.383
,2013, 'Global kidney disease', The Lancet, 382, pp. 1243, http://dx.doi.org/10.1016/S0140-6736(13)62086-3
,2013, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD004289.pub5
,2013, 'Intensive glucose control improves kidney outcomes in patients with type 2 diabetes', Kidney International, 83, pp. 517 - 523, http://dx.doi.org/10.1038/ki.2012.401
,2013, 'Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS) - A randomized placebo-controlled trial', American Heart Journal, 166, http://dx.doi.org/10.1016/j.ahj.2013.05.007
,2013, 'The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus', Heart, Lung and Circulation, 22, pp. S68 - S68, http://dx.doi.org/10.1016/j.hlc.2013.05.162
,2012, 'Trials in kidney disease - Time to EVOLVE', New England Journal of Medicine, 367, pp. 2541 - 2542, http://dx.doi.org/10.1056/NEJMe1212368
,2012, 'Antihypertensive agents for preventing diabetic kidney disease', Cochrane Database of Systematic Reviews, 2012, http://dx.doi.org/10.1002/14651858.CD004136.pub3
,2012, 'Effects of fibrates in kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 60, pp. 2061 - 2071, http://dx.doi.org/10.1016/j.jacc.2012.07.049
,2012, 'Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis', Circulation: Cardiovascular Quality and Outcomes, 5, pp. 808 - 818, http://dx.doi.org/10.1161/CIRCOUTCOMES.112.966168
,2012, 'Prediction of kidney-related outcomes in patients with type 2 diabetes', American Journal of Kidney Diseases, 60, pp. 770 - 778, http://dx.doi.org/10.1053/j.ajkd.2012.04.025
,